Clinical usefulness of intravenous human immunoglobulins in invasive group A Streptococcal infections: case report and review.

Abstract

The spectrum of invasive Streptococcus pyogenes (group A streptococcus) infections includes bacteremia, toxic shock syndrome, and necrotizing fasciitis or myositis. We report the successful use of intravenous immunoglobulins in conjunction with antibiotics and surgery in a case of necrotizing myositis, toxic shock, and bacteremia. A literature review revealed that three other patients with invasive group A streptococcal infections had been treated with immunoglobulins: one adult patient had toxic shock syndrome, one had necrotizing fasciitis, and one child had septic arthritis. On the basis of this report and the review, we suggest that intravenous immunoglobulins may be useful in the treatment of all forms of invasive group A streptococcal infections associated with toxic shock syndrome.

• Authors: F Lamothe, P D'Amico, P Ghosn, C Tremblay, J Braidy, J V Patenaude
• Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (Clin Infect Dis) Vol. 21 Issue 6 Pg. 1469-70 (Dec 1995) ISSN: 1058-4838 [Print] United States
• PMID: 8749635 (Publication Type: Case Reports, Journal Article)

Chemical References

• Immunoglobulins, Intravenous

Topics

• Humans
• Immunoglobulins, Intravenous (therapeutic use)
• Male
• Middle Aged
• Myositis (microbiology, pathology, therapy)
• Shock, Septic (microbiology, therapy)
• Streptococcal Infections (physiopathology, therapy)
• Streptococcus pyogenes (isolation & purification)